SPAC Daily: 2 DAs Highlight a Quiet Market

by | Sep 29, 2022

It’s been a rather quiet going in SPAC land amidst a very nasty broader equity market (save for extension votes of course). Today the “highlight” saw two new definitive agreements hit the tape, one in the morning and one post close.

  • Consumer Direct Holdings is going public via DTRT Health Acquisition (DTRT) in a $681M EV deal that includes $150M of debt financing
  • YS Biopharma, a Chinese rabies vaccine company, struck a deal with Summit Healthcare Acquisition Corp. (SMIH)

That brings us to 6 new DAs on the week, which is almost shocking considering the tumult in equities. Issuance is still quiet for a few weeks now, though rumor has it two SPACs will be pricing tonight including one from SPAC veterans dMY. So look out for that.

Elsewhere in SPACs

  • Northern Lights Acquisition (NLIT) and Safe Harbor Financial finally closed their SPAC deal 3 months after the vote. SHFS closed down 15% on its first day of trading to close at $8.74
  • Liberty Media Acquisition Corporation (LMACA) filed a preliminary proxy to move its liquidation date up to 2022 (perhaps to avoid the excise tax). Big sponsor goes down
  • Brilliant Acquisition Corp. (BRLI) to double up to 1,012,000 (or the equivalent of 40% of all outstanding shares and rights in connection with its merger vote
  • Atlantic Avenue Acquisition (ASAQ) adjourned its planned extension vote out till 10/4
  • Executive Partnering Corp. (ENPC) set a 10/20 date for its Granite Ridge Vote

SPAC Calendar

Today’s Movers

Biggest Gainers

Biggest Losers

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – July 2022

Liquidations, cancelled deals, and a dead IPO market highlight Boardroom Alpha’s July 2022 SPAC market review. Read for a full recap.

SPAC Market Review – June 2022

Boardroom Alpha’s June 2022 SPAC market review looks at the latest trends in SPACs, where the market is heading a recap of activity.

SPAC Market Review ‚Äď May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

SPAC Research & Analysis

Boardroom Alpha Digest: Mon, Jan 9

Rite Aide Corporation (RAD) parts ways with Heyward Donigan and Paya Holdings (PAYA) acquisition highlight Monday’s daily digest.

Boardroom Alpha Digest: Thurs, Jan 5

Boardroom Alpha’s Daily Digest highlights include Elizabeth Spaulding resigning as CEO of Stitch Fix (SFIX) and JNJ’s Kenvue filing for an IPO

SPAC Market Review – December 2022

December’s SPAC market review takes a look by the numbers of the month’s SPAC activity and how the market currently stands going into 2023.

SPACs Today: Wednesday, Dec 14

Rice Acquisition Corp. II (RONI) with an encouraging energy transaction, and the rest of the day’s SPAC news.

SPACs Today: Monday, Dec 12

Venus Acquisition Corporation (VENA) finally closed and changes ticker to MLGO, and the rest of the day’s SPAC news.

SPAC Market Review – November 2022

November’s SPAC market review paints a picture of a SPAC market rushing towards the exit with high, and accelerating liquidations, more deal terminations, and almost no new SPAC IPOs.

Know Who Drives Return Podcast

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. WindAcre increases its stake and opposes NSLN takeover bid. Activist Jana Partners brings lessons learned at ConAgra (CAG) to Treehouse Foods (THS). And other notable special situations.

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. Management shakeup at Faraday Future (FIFE) is an all-too familiar story in the world of EV SPACs. Blackrock to be 75% net-zero aligned by 2030, and Jana closing in (again) at Treehouse Foods (THS).

FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry

Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational¬†purposes only¬†‚Äď it does not constitute investment, legal or tax advice. You should not¬†rely solely upon the research herein for¬†purposes of transacting securities or other investments, and you are¬†encouraged to conduct your own research and due diligence, and to seek¬†the advice of a qualified¬†securities professional before¬†you make any¬†investment.¬†¬†

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.